Membrane Distillation Provides a Dual Barrier for Coronavirus and Bacteriophage Removal
Author(s) -
Mukta Hardikar,
Luisa A. Ikner,
Varinia Felix,
Luke K. Presson,
Andrew B. Rabe,
Kerri L. Hickenbottom,
Andrea Achilli
Publication year - 2021
Publication title -
environmental science and technology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.497
H-Index - 58
ISSN - 2328-8930
DOI - 10.1021/acs.estlett.1c00483
Subject(s) - membrane distillation , reverse osmosis , wastewater , ultrafiltration (renal) , effluent , chemistry , microfiltration , membrane , murine norovirus , virus , bacteriophage ms2 , norovirus , membrane technology , filtration (mathematics) , chromatography , desalination , bacteriophage , virology , biology , environmental science , environmental engineering , escherichia coli , biochemistry , statistics , mathematics , gene
The persistence of pathogenic microorganisms in treated wastewater effluent makes disinfection crucial to achieve wastewater reuse. Membrane processes such as ultrafiltration and reverse osmosis (RO) have shown promising results for virus and other contaminant removal from treated wastewater effluents for reuse application. However, RO produces a concentrate stream which contains high concentrations of pathogens and contaminants that often requires treatment and volume reduction before disposal. Membrane distillation (MD) is a treatment process that can reduce RO concentrate volume while augmenting the potable water supply. MD is also a dual barrier approach for virus removal as it operates at a high temperature and permeates only the vapor phase through the membrane interface. The effects of temperature on viable virus concentration and membrane rejection of viruses in MD are investigated in this study using two nonenveloped phages frequently used as enteric virus surrogates (MS2 and PhiX174) and an enveloped pathogenic virus (HCoV-229E). At typical MD operating temperatures (greater than 65 °C), viable concentrations of all three viruses were reduced by thermal inactivation by more than 6-log 10 for MS2 and PhiX174 and more than 3-log 10 for HCoV-229E. Also, membrane rejection was greater than 6-log 10 for MS2 and PhiX174 and greater than 2.5-log 10 for HCoV-229E.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom